Loading stock data…
GRF
$10.33+0.13 (+1.27%)
Market ClosedLast close May 1
Eagle Capital Growth Fund, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Eagle Capital Growth Fund, Inc. in the Financial Services sector is trading at $10.33. The stock is currently 13% below its 52-week high of $11.85, remaining 1.7% above its 200-day moving average. Technical signals show neutral RSI of 50 and bullish MACD crossover, explaining why GRF maintains its current momentum and trend strength. The Whystock Score of 80/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 50) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$10.33
Potential Upside
124.3%
Whystock Fair Value$23.17
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Eagle Capital Growth Fund, Inc. is a closed-end equity mutual fund launched and managed by Sims Capital Management LLC. The fund invests in the public equity markets of the United States. It makes its investments in the stocks of companies operating ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$40.43M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
8.02
Beta
Defensive asset. Lower volatility than the S&P 500.
0.28
Div Yield
Strong income play. Yield provides a meaningful total return floor.
8.23%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
1,225
Recent News
Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
Recent performance context for Grifols Grifols (BME:GRF) has drawn investor attention after a mixed run, with a modest 1 day gain, a negative move over the past week and month, and a deeper decline across the past 3 months. Over a longer horizon, the stock shows a positive 1 year total return but weaker 3 year and 5 year total returns, prompting some investors to reassess how current pricing lines up with the company’s underlying business. See our latest analysis for Grifols. Recent trading...
Is Grifols (BME:GRF) Offering Value After Recent Share Price Swings?
Wondering whether Grifols at €9.27 is offering value right now, or if the recent price is already baking in most of the good news? The stock has had a mixed run, with a 3.5% gain over the last 7 days, an 11.9% decline over 30 days, a 17.2% decline year to date, but an 11.6% return over the past year. These swings sit against a longer track record of a 3.6% return over 3 years and a 57.6% decline over 5 years, which can influence how you think about risk and patience. Together, these figures...
Grifols Plans IPO of U.S. Biopharma Business
The Spanish pharmaceutical company is looking to raise money to bolster its balance sheet and fund investments.